China Pharmaceutical Robots Market Size & Outlook
China pharmaceutical robots market, 2016-2030 (US$M)
Related Markets
China pharmaceutical robots market highlights
- The China pharmaceutical robots market generated a revenue of USD 67.5 million in 2023 and is expected to reach USD 111.6 million by 2030.
- The China market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
- In terms of segment, traditional robots was the largest revenue generating type in 2023.
- Collaborative Robots is the most lucrative type segment registering the fastest growth during the forecast period.
Pharmaceutical robots market data book summary
| Market revenue in 2023 | USD 67.5 million |
| Market revenue in 2030 | USD 111.6 million |
| Growth rate | 7.4% (CAGR from 2023 to 2030) |
| Largest segment | Traditional robots |
| Fastest growing segment | Collaborative Robots |
| Historical data | 2016 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Traditional Robots, Collaborative Robots |
| Key market players worldwide | ABB Ltd, Teradyne Inc, Kawasaki Heavy Industries Ltd, YASKAWA Electric Corp, Fanuc Corp, Marchesini Group, Seiko Epson Corp, Denso Corp, Mitsubishi Electric Corp, KUKA Robotics |
Other key industry trends
- In terms of revenue, China accounted for 33.8% of the global pharmaceutical robots market in 2023.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China pharmaceutical robots market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 5.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Robots Market Scope
Pharmaceutical Robots Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China pharmaceutical robots market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical robots market will help companies and investors design strategic landscapes.
Traditional robots was the largest segment with a revenue share of 62.37% in 2023. Horizon Databook has segmented the China pharmaceutical robots market based on traditional robots, collaborative robots covering the revenue growth of each sub-segment from 2016 to 2030.
According to an article published by Robotics & Automation in October 2020, China accounted for the largest share (140,500 units) of industrial robot installations around the world. This was mainly the result of considerable increase in sales in China.
Rise in the demand for production of drugs and development of robotic machines for performing tasks with high speed, reduced risk of contamination, accuracy, and optimum utilization of space among pharmaceutical companies are boosting the market growth in the country. Moreover, rise in the number of initiatives undertaken by Chinese government to increase the adoption of industrial robots in the country is driving the market growth.
For instance, in 2016, the Chinese government launched the Robotics Industry Development Plan (2016-2020), aimed at promoting robot applications to a wider range of fields and attracting foreign investment, to develop 100,000 industrial robots produced by domestic technology annually by 2020.
Reasons to subscribe to China pharmaceutical robots market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China pharmaceutical robots market databook
-
Our clientele includes a mix of pharmaceutical robots market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China pharmaceutical robots market , including forecasts for subscribers. This country databook contains high-level insights into China pharmaceutical robots market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China pharmaceutical robots market size, by type, 2016-2030 (US$M)
China Pharmaceutical Robots Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
